Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Biotech Stocks
Biotech Stocks page aggregates 6 articles covering catalysts, earnings moves, and company updates to help you spot opportunities and manage biotech investments more confidently.
72 articlesBiohaven Stock Down Fund's Turnaround Bet Sparks Hope
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
This Biotech Stock Winner Is Up 72%, but Trim Signals Reset
A biotech stock winner has surged 72%, yet a disciplined stake trim suggests a cautious pause. Here’s how to read the...
Taysha (TSHA) 2025 Earnings Outlook and Q4 Review
As Taysha prepares to share Q4 2025 results, investors search for clarity on cash runway, pipeline progress, and futu...
Signal Noise: What Adviser's Trades Signal to Investors
Insider trades can hint at a company's future, but not every move is meaningful. This article shows how to filter sig...
Better Weight Loss Drug Stock: Lilly vs Viking Therapeutics
The weight loss drug space has become a focus for growth-minded investors. This guide weighs Eli Lilly's proven progr...
Oncology Institute (TOI) Earnings: A Deep Dive for Investors
When TOI releases earnings, investors watch more than headline numbers. This guide breaks down TOI earnings, what dri...
Edgewise Therapeutics Stock Topped: Tuesday Rally Explained
A Tuesday uptick in Edgewise Therapeutics stock topped the market, driven by an upbeat price target from a major bank...
Cibus (CBUS) 2025 Earnings: What Investors Should Watch
As 2025 earnings season hits, savvy investors need a clear playbook for cibus (cbus) 2025 earnings. This guide breaks...
Abeona (ABEO) 2025 Earnings: What Investors Should Watch Now
As Abeona prepares to report 2025 results, investors need a clear framework to interpret the numbers. This guide brea...
This Biotech Stock 700%: Top Holding After $9.3M Sale
A biotech stock that surged 700% remains a cornerstone of many portfolios even after a sizable last-quarter sale by a...
Related Topics
#Investing (55)
#Stock Analysis (16)
#Earnings Analysis (16)
#Stock Market News (11)
#Earnings (8)
#Stock Market (7)
#Portfolio Management (7)
#Insider Trading (7)
#Portfolio Strategy (6)
#risk-management (5)
#Hedge Funds (5)
#Investing Strategies (3)
#Investing Strategy (3)
#CRISPR (3)
#Viking Therapeutics (3)